European Medicines Agency - Veterinary medicines - Loxicom
Apr 2, 2017 - (spaying) and minor soft-tissue surgery. Loxicom solution for injection (20 mg/ml) is used in cattle, together with appropriate antibiotic therapy ...
European Medicines Agency - Science, medicines, health
Loxicom meloxicam Next tab » This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use. This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR). Expand all items in this list What is Loxicom? Loxicom is a medicine that contains the active substance meloxicam. It is available as oral suspensions (0.5 mg/ml and 1.5 mg/ml), as oral paste (50 mg/g), as chewable tablets (1 mg and 2.5 mg) and solutions for injection (5 mg/ml, and 20 mg/ml). Loxicom is a ‘generic’ which means that Loxicom is similar to a ‘reference veterinary medicine’ already authorised in the EU (Metacam). What is Loxicom used for? Loxicom oral suspensions are used to relieve inflammation and pain in cats and dogs. They can be used for chronic (long-term) musculoskeletal disorders, and in dogs it can also be used for acute (sudden and short-lived) musculoskeletal disorders, for instance, due to injury. Loxicom oral paste (50 mg/g) is used to relieve inflammation and pain in both acute and chronic musculoskeletal disorders in horses. Loxicom chewable tablets can be used in dogs to relieve inflammation and pain in chronic musculoskeletal disorders as well as in acute disorders. Loxicom solution for injection (5 mg/ml) can be used to relieve inflammation and pain in dogs following surgery involving the bones or soft tissue and in cats following ovariohysterectomy (spaying) and minor soft-tissue surgery. Loxicom solution for injection (20 mg/ml) is used in cattle, together with appropriate antibiotic therapy, to reduce clinical signs in acute respiratory infections (infection of the lungs and airways) and to treat acute mastitis (inflammation of the udder). It can be used in combination with oral rehydration therapy (medicines given by mouth to restore water levels in the body) for diarrhoea in calves of over one week of age and in young, non-lactating cattle. Loxicom solution for injection (20 mg/ml) is used in pigs to reduce the symptoms of lameness and inflammation in noninfectious locomotor disorders (diseases that affect the ability to move)
02/04/2017 19:02
European Medicines Agency - Veterinary medicines - Loxicom
and for the treatment of diseases that occur after farrowing (giving birth) such as puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome), together with appropriate antibiotic therapy. Septicaemia and toxaemia are conditions where bacteria circulate in the blood and produce harmful substances. Loxicom solution for injection (20 mg/ml) is used in horses to relieve colic (abdominal pain) and the inflammation and pain in acute and chronic musculoskeletal disorders. How does Loxicom work? How has Loxicom been studied? What benefit has Loxicom shown during the studies? What is the risk associated with Loxicom? What is the withdrawal period? What are the precautions for the person who gives the medicine or comes into contact with the animal? Why has Loxicom been approved? Other information about Loxicom Name
Loxicom : EPAR - Summary for the public
Language Select a language to view the document
First published
12/02/2009
Last updated
24/04/2013
This EPAR was last updated on 22/08/2016 . More detail is available in the summary of product characteristics Share Loading
Apr 2, 2017 - In cattle, Metacam is used together with appropriate antibiotic therapy, to reduce clinical signs of disease, in acute (short-term) respiratory ...
28 nov. 2016 - Scope (accelerated assessment): Treatment of neuronal ceroid lipofuscinosis type 2. Action: For adoption of PRAC RMP AR, PRAC RMP assessment overview and advice to CHMP. 5.1.4. Fluciclovine (18F) - EMEA/H/C/004197. Scope: Diagnostic ag
28 nov. 2016 - Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes listed against products, it must be
5 oct. 2015 - cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence. Immunostimulants. Cediranib (maleate). Antineoplastic medicines. Chlormethine. Antineoplastic medicines. Daratumumab. Antineoplastic medicines.
24 août 2016 - The PDCO adopted 1 opinion on the refusal of a request for waiver for: â¢. 18F fluoromisonidazole, EMEA-001977-PIP02-16, from RadioMedic ...
2 juin 2010 - Lamivudine pour conformité du système 1 SCR,. Clarithromycine pour ...... matrice de l'échantillon, et de ceux dont la surface est inférieure ou ...
9 juil. 2015 - ... haemorrhages and epistaxis, and present a classification of the ...... 4 cross-sectional study of bone mineral density in HIV-1 infected ...
2 juin 2010 - obtenue à partir du sérum ou du plasma de jument gravide, possédant des activités ...... acides aminés ne sont présents qu'à l'état de traces.
duodenal lesions in dogs and cats. ESFM â European Society .... treatment status, acceptance by the patient, response to therapy, and owner adherence to therapeutic .... cultured dog gallbladder epithelial cells, bacterial infection is associated w
Dec 10, 2004 - (2) The Commission Regulation specifies the conditions for the Agency to issue approvals for changes and repair designs for products for ...
failure of any emergency system during scheduled testing. .... recommendations but will show the relationship to such recommendations. 6. ...... It is acceptable to combine any or all of the office accommodation requirements into one ...... (e) Quest
Jun 5, 2009 - CS23.865, Fire protection of flight controls, engine mounts and ... Minimum Control Speed VMC. 62 KIAS (62 ... Illustrated Parts Catalogue.
the DG Education and Culture of the European Commission: ...... dysgrafia, dysarithmisia, dysanagnwsia, dysorthografia, attention deficit syndrome with or ...
dernier, c'est-à -dire le rapport de synthèse du projet. Le document « matrice » extrait des informations des documents politiques et des travaux de recherche, ...
Un document « matrice » reliant les éléments de base du projet directement ...... également être « trop absorbés par la conformité et la poursuite défensive de ...
Any discrimination based on any ground such as sex⦠or sexual orientation ... Agency for Fundamental Rights can be ordered via its website free of charge.
20 juin 2016 - Galileo is Europe's global navigation satellite system, providing a highly accurate, guaranteed global positioning service under civilian control.
Cataract surgery was very important in ... Development of residencies and research programs. Cataract Surgery ... Encourage education, research and practice ...
the urinad bladder, the trigone mucosa, and the prox- imal urethra in both males and .... PC, and Palmer N, 4th ed., vol. 3, pp. 523-529. Aca- demic Press, New ...
Jul 29, 2010 - D. A. PASS, J. R. BOLTON, and J. N. MILLS. Chronic enteric disease in the horse has been associated with granulomatous' and eosinophilic' ...
